MetaStat, Inc. (MTST)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0842 (-99.76%)
At close: Aug 7, 2025
MetaStat Market Cap
MetaStat has a market cap or net worth of $1.18 thousand as of September 11, 2025. Its market cap has decreased by -99.97% in one year.
Market Cap
1.18K
Enterprise Value
n/a
Revenue
23.30K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 28, 2012, MetaStat's market cap has decreased from 9.62M to 1.18K, a decrease of -99.99%. That is a compound annual growth rate of -48.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 1.18K | -96.43% |
| Dec 31, 2020 | 32.91K | 74.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 608.81M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |